ArticleDepression and anxiety2026
Major Depressive Disorder With Versus Without Psychosocial Triggers: A Secondary Analysis of a Prospective Cohort Study.
Article in Depression and anxiety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Major Depressive Disorder With Versus Without Psychosocial Triggers: A Secondary Analysis of a Prospective Cohort Study.Depression and anxiety · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Few studies have examined differences in symptom presentation and antidepressant response between patients with major depressive disorder (MDD) with and without psychosocial triggers. Methods: This was a secondary analysis of a multicenter, multistage prospective cohort study conducted at nine top tertiary hospitals across six provinces/municipalities in China. The cohort included patients with first-episode MDD, with or without psychosocial triggers, who received one of six selective serotonin reuptake inhibitors (SSRIs). Results: Of 359 enrolled patients with first-episode MDD, 303 (mean [SD] age, 39.6 [10.1] years; 201 [66.8%] women) were included in the final analysis. There were no significant differences in network structure ( Conclusions: While patients with MDD with and without psychosocial triggers shared broadly similar clinical profiles and SSRI responses, differences in symptom network architecture may have implications for individualized symptom monitoring and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.